Melanoma drug extends life in second large study
by on Jun.05, 2011, under Health and Fitness
People with advanced melanoma who were treated with Bristol-Myers Squibb Co's Yervoy plus chemotherapy lived an average of two months longer than people who got chemotherapy alone, in the first of many combination studies slated for this promi…
View full post on Yahoo! Health News
